DEF 14A

Company

Benitec Biopharma Inc.

Filed

October 20, 2023

Period of Report

December 6, 2023

Accession Number

0001193125-23-259531

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →